These in vitro experiments have provided mechanistic insight into how IRE1 can become activated in TNBC and how XBP1 can drive tumour progression through direct interaction with other transcription factors, and through modulation of the tumour secretome [9,24,30]. Here, XBP1 is linked to neoplasm.